EU OK for Roche’s oral flu treatment Xofluza
Oral treatment approved to treat uncomplicated influenza and for post-exposure prophylaxis
Read More
Tag: Xofluza
Six new medicines leap towards EU approval
The recommendations include new treatments for cancer and intraocular pressure and prevention of uncomplicated flu.
Read More
Xofluza effective as preventative flu medicine
Xofluza is the first and only one-dose oral medicine approved to treat flu in otherwise healthy patients.
Read More
US approves first-in-class flu drug
The US Food and Drug Administration has approved Roche/Shionogi & Co’s Xofluza for the treatment of acute uncomplicated flu, opening the door to the first new antiviral with a novel mechanism of action in nearly 20 years.
Read More
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
- BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development
- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
